SQZ Biotechnologies’ $60 Million Common Stock Offering

Martina Bellini North America, North America Legal Chronicle
Tagged:

Latham & Watkins LLP represented SQZ Biotechnologies Company in the transaction.SQZ Biotechnologies Company (NYSE: SQZ) (SQZ), a cell therapy company developing novel treatments for multiple therapeutic…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here